KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Insulet (PODD) Research & Development (2016 - 2026)

Insulet filings provide 16 years of Research & Development readings, the most recent being $90.9 million for Q4 2025.

  • On a quarterly basis, Research & Development rose 50.0% to $90.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $301.1 million, a 37.11% increase, with the full-year FY2025 number at $301.1 million, up 37.11% from a year prior.
  • Research & Development hit $90.9 million in Q4 2025 for Insulet, up from $77.2 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $90.9 million in Q4 2025 to a low of $37.5 million in Q3 2021.
  • Median Research & Development over the past 5 years was $50.2 million (2023), compared with a mean of $53.3 million.
  • Biggest five-year swings in Research & Development: fell 15.15% in 2023 and later soared 50.0% in 2025.
  • Insulet's Research & Development stood at $41.8 million in 2021, then rose by 18.42% to $49.5 million in 2022, then dropped by 15.15% to $42.0 million in 2023, then skyrocketed by 44.29% to $60.6 million in 2024, then soared by 50.0% to $90.9 million in 2025.
  • The last three reported values for Research & Development were $90.9 million (Q4 2025), $77.2 million (Q3 2025), and $73.4 million (Q2 2025) per Business Quant data.